Endocrine Pharmacology Practice Questions

Q: Which drug is used for the management of obesity?

Orlistat. **Explanation:** **Correct Option: A. Orlistat** Orlistat is a potent, specific, and long-acting **inhibitor of gastric and pancreatic lipases**. Its mechanism of action involves forming a covalent bond with the active serine site of these enzymes in the lumen of the stomach and small intestine. This prevents the hydrolysis of dietary fat (triglycerides) into absorbable free fatty acids and monoglycerides. Consequently, approximately 30% of dietary fat remains unabsorbed and is excreted in the feces, leading to a caloric deficit and weight loss. **Incorrect Options:** * **B. Rivastigmine:** A pseudo-irreversible acetylcholinesterase inhibitor used primarily in the management of **Alzheimer’s disease** and Parkinson’s dementia. * **C. Nitrous oxide:** An inhalational anesthetic gas (Laughing gas) used for **general anesthesia** and analgesia. * **D. Phenylephrine:** A selective **$\alpha_1$-adrenergic agonist** used as a nasal decongestant and a pressor agent to treat hypotension. **Clinical Pearls for NEET-PG:** * **Side Effects of Orlistat:** Due to fat malabsorption, it commonly causes **steatorrhea** (oily spotting), flatus with discharge, and fecal urgency. It can also interfere with the absorption of **fat-soluble vitamins (A, D, E, K)**; supplementation is often required. * **Other FDA-approved drugs for Obesity:** * **Liraglutide/Semaglutide:** GLP-1 receptor agonists (injectable). * **Phentermine/Topiramate:** Combination therapy (sympathomimetic + antiepileptic). * **Naltrexone/Bupropion:** Combination targeting reward pathways. * **Lorcaserin:** 5-HT$_{2C}$ agonist (withdrawn in many regions due to cancer risk).

Q: A 45-year-old female patient with a history of diabetes, currently on oral hypoglycemic medication, presents for a routine general checkup. Physical examination reveals truncal obesity. The medication used in her treatment acts by inhibiting which of the following enzymes?

CPT-I. **Explanation:** The patient is likely being treated with **Etomoxir** or **Moxonidine**, though in the context of diabetes management and CPT-I inhibition, the question refers to the mechanism of **Etomoxir** or the physiological inhibition by **Malonyl-CoA**. **Why CPT-I is correct:** Carnitine Palmitoyltransferase-I (CPT-I) is the rate-limiting enzyme for the entry of long-chain fatty acids into the mitochondria for **beta-oxidation**. In diabetes, excessive fatty acid oxidation contributes to hyperglycemia by stimulating gluconeogenesis and inhibiting glucose utilization (the Randle Cycle). Inhibitors of CPT-I shift the metabolism from fatty acid oxidation to glucose oxidation, thereby improving insulin sensitivity and lowering blood glucose levels. **Analysis of Incorrect Options:** * **A. 3-KetoacylCoA thiolase:** This is the target of **Trimetazidine**, an anti-anginal drug. While it also shifts metabolism from fatty acids to glucose, it acts on the final step of beta-oxidation, not the transport step. * **B. HMG-CoA lyase:** This enzyme is involved in **ketogenesis** (converting HMG-CoA to acetoacetate) and leucine catabolism. It is not a target for standard oral hypoglycemic agents. * **D. 3-hydroxyacyl-CoA dehydrogenase:** This is an enzyme involved in the third step of the beta-oxidation cycle. While essential for fat metabolism, it is not the primary target of clinical CPT-I inhibitors. **NEET-PG High-Yield Pearls:** * **Malonyl-CoA** is the physiological inhibitor of CPT-I; its levels rise when insulin is high, preventing fatty acid breakdown during the fed state. * **CPT-I** is located on the outer mitochondrial membrane, while **CPT-II** is on the inner membrane. * Drugs shifting metabolism from fatty acids to glucose (like CPT-I inhibitors or p-FOX inhibitors) are termed **metabolic modulators**.

Q: Which of the following medications are used in the treatment of postmenopausal osteoporosis?

Alendronate. **Explanation:** **Correct Option: D (Alendronate)** Alendronate is a **Bisphosphonate**, which is the first-line pharmacological treatment for postmenopausal osteoporosis. It works by inhibiting **osteoclast-mediated bone resorption**. Bisphosphonates are structural analogs of pyrophosphate; they bind to hydroxyapatite crystals in the bone and inhibit the enzyme **farnesyl pyrophosphate synthase**, leading to osteoclast apoptosis and increased Bone Mineral Density (BMD). **Analysis of Incorrect Options:** * **A. Tamoxifen:** This is a Selective Estrogen Receptor Modulator (SERM) used primarily in breast cancer. While it has pro-estrogenic effects on bone, **Raloxifene** is the specific SERM preferred for osteoporosis because it does not increase the risk of endometrial cancer. * **B. Progesterone:** Progesterone alone does not have a significant role in increasing BMD or treating osteoporosis. It is primarily used in Hormone Replacement Therapy (HRT) to counteract the stimulatory effects of estrogen on the endometrium. * **C. Estrogen:** While Estrogen Replacement Therapy (ERT) is effective in preventing bone loss, it is no longer the first-line treatment for osteoporosis due to the increased risk of breast cancer, stroke, and thromboembolism (as per WHI guidelines). **High-Yield Clinical Pearls for NEET-PG:** * **Administration:** Alendronate must be taken on an empty stomach with a full glass of water, and the patient must remain upright for 30 minutes to prevent **erosive esophagitis**. * **Adverse Effects:** Long-term use is associated with **Osteonecrosis of the Jaw (ONJ)** and atypical subtrochanteric fractures. * **Teriparatide:** A recombinant PTH analog, it is the only **anabolic agent** (stimulates bone formation) used in severe osteoporosis.

Q: Which of the following is NOT a side effect of steroids given in anti-inflammatory dosages?

Hyperkalemia. Glucocorticoids (steroids) exert significant metabolic and mineralocorticoid effects when used in anti-inflammatory dosages. Understanding their impact on electrolytes and metabolism is crucial for the NEET-PG exam. ### **Why Hyperkalemia is the Correct Answer** Steroids do **not** cause hyperkalemia; instead, they cause **hypokalemia**. Glucocorticoids have a cross-reactivity with mineralocorticoid receptors (aldosterone receptors) in the distal renal tubules. This leads to the activation of the Na+/K+ pump, resulting in sodium reabsorption and the **excretion of potassium (K+) and hydrogen ions (H+)**. Therefore, steroid therapy is associated with hypokalemic alkalosis, not hyperkalemia. ### **Explanation of Incorrect Options** * **A. Diabetes Mellitus:** Steroids are "diabetogenic." They increase gluconeogenesis in the liver and decrease peripheral glucose uptake (insulin resistance), leading to hyperglycemia and steroid-induced diabetes. * **C. Osteoporosis:** Steroids inhibit osteoblast activity, enhance osteoclast activity, and decrease intestinal calcium absorption. This makes osteoporosis one of the most serious long-term side effects. * **D. Na+ and Water Retention:** Due to their mineralocorticoid-like action, steroids promote sodium and water retention, which can lead to edema and hypertension. ### **High-Yield Clinical Pearls for NEET-PG** * **Most common side effect (Long-term):** Osteoporosis (Prophylaxis with Bisphosphonates is often recommended). * **Ocular side effects:** Glaucoma (due to increased intraocular pressure) and Posterior Subcapsular Cataracts. * **Hematological effect:** Steroids cause **lymphopenia** and **eosinopenia** but lead to **neutrophilia** (due to demargination of neutrophils from blood vessel walls). * **Growth:** Steroids cause growth retardation in children by inhibiting growth hormone axis and direct effects on epiphyseal plates.

Q: All of the following are indications for the use of Mifepristone, EXCEPT:

Postpartum hemorrhage (PPH). **Explanation:** Mifepristone is a potent **synthetic steroid** that acts primarily as a **progesterone receptor antagonist** (and at higher doses, a glucocorticoid receptor antagonist). **Why Postpartum Hemorrhage (PPH) is the correct answer:** Mifepristone is **not** used in the management of PPH. PPH requires uterotonic agents (like Oxytocin, Carboprost, or Misoprostol) to cause uterine contraction. Mifepristone, by blocking progesterone, actually increases uterine sensitivity to prostaglandins but does not provide the immediate, sustained contraction needed to stop acute bleeding. **Analysis of other options:** * **Abortion:** Mifepristone is the drug of choice for medical termination of pregnancy (MTP) up to 7 weeks (often used up to 9-10 weeks) in combination with Misoprostol. It causes decidual necrosis and cervical softening. * **Cushing Syndrome:** Due to its anti-glucocorticoid properties, Mifepristone is FDA-approved for controlling hyperglycemia secondary to hypercortisolism in patients with endogenous Cushing syndrome. * **Cervical Ripening:** It is used for pre-induction cervical ripening and in the management of intrauterine fetal death (IUFD) to facilitate labor induction. **High-Yield Clinical Pearls for NEET-PG:** * **Mechanism:** Competitive antagonist at Progesterone (PR-A and PR-B) and Glucocorticoid receptors. * **MTP Protocol:** 200 mg Mifepristone orally, followed 36-48 hours later by 800 mcg Misoprostol (vaginal/sublingual/buccal). * **Other Uses:** Emergency contraception (10 mg dose), management of uterine fibroids (reduces size), and endometriosis. * **Key Contraindication:** Chronic adrenal failure and ectopic pregnancy.

Q: Anabolic steroids may produce the following side effects except?

Delayed closure of epiphysis in children. Anabolic steroids are synthetic derivatives of testosterone designed to maximize anabolic effects (muscle building) while minimizing androgenic effects. However, they carry a significant side-effect profile due to their hormonal nature. **Why Option C is the Correct Answer:** Anabolic steroids do **not** cause delayed closure of the epiphysis; rather, they cause **premature closure of the epiphysis**. In children and adolescents, high levels of androgens (or their conversion into estrogens) accelerate the fusion of the epiphyseal growth plates. This leads to a sudden growth spurt followed by a permanent cessation of linear growth, ultimately resulting in short stature [3]. **Analysis of Incorrect Options:** * **A. Precocious Puberty:** In children, exogenous androgens trigger the development of secondary sexual characteristics (e.g., pubic hair, deepening of voice) prematurely, leading to isosexual precocity [1]. * **B. Cholestatic Jaundice:** 17-α alkylated steroids (like Oxymetholone or Methyltestosterone) are particularly hepatotoxic. They can cause intrahepatic cholestasis, peliosis hepatis (blood-filled cysts in the liver), and an increased risk of hepatic carcinoma [1]. * **D. Acne:** Androgens stimulate the sebaceous glands to produce excess sebum, which leads to acne in both males and females [1]. **High-Yield Clinical Pearls for NEET-PG:** * **Virilization:** In females, anabolic steroids cause hirsutism, clitoral hypertrophy, and menstrual irregularities [1]. * **Azoospermia:** In males, exogenous steroids suppress the Hypothalamic-Pituitary-Gonadal (HPG) axis via negative feedback, leading to testicular atrophy and infertility [1], [2]. * **Lipid Profile:** They typically decrease HDL and increase LDL, significantly raising cardiovascular risk [1]. * **Psychiatric Effects:** High doses are associated with "Roid Rage" (increased aggression and irritability) [1].

Q: Which vitamin deficiency is most commonly seen in a pregnant mother who is on phenytoin therapy for epilepsy?

Folic acid. **Explanation:** Phenytoin is a classic inducer of hepatic cytochrome P450 enzymes and is well-known for its interference with folate metabolism. **Why Folic Acid is Correct:** Phenytoin causes **Folic acid deficiency** through three primary mechanisms: 1. **Inhibition of intestinal absorption:** It inhibits the enzyme intestinal conjugase, which is required to convert dietary polyglutamates into absorbable monoglutamates. 2. **Increased catabolism:** It induces hepatic enzymes that accelerate the breakdown of folate. 3. **Antagonism:** It acts as a weak competitive antagonist of folate. In pregnancy, this deficiency is particularly critical as it significantly increases the risk of **Neural Tube Defects (NTDs)** and can lead to megaloblastic anemia in the mother. **Why Other Options are Incorrect:** * **Vitamin B6 (Pyridoxine):** Deficiency is classically associated with **Isoniazid (INH)** therapy (due to the formation of hydrazones), not phenytoin. * **Vitamin B12:** While B12 deficiency also causes megaloblastic anemia, phenytoin specifically targets folate pathways. B12 levels are generally unaffected by anticonvulsants. * **Vitamin A:** Phenytoin does not interfere with the absorption or metabolism of fat-soluble Vitamin A. **NEET-PG High-Yield Pearls:** * **Fetal Hydantoin Syndrome:** Characterized by cleft lip/palate, microcephaly, and hypoplastic phalanges/nails. * **Vitamin K Deficiency:** Phenytoin can also cause Vitamin K deficiency in the neonate, leading to **neonatal coagulation defects**. Prophylactic Vitamin K is often given to the mother in the last month of pregnancy. * **Management:** Pregnant women on phenytoin should receive high-dose folic acid (5 mg/day) to reduce the risk of NTDs.

Q: Third generation oral contraceptive pills containing norgestrel and gestodene along with estrogens:

Are more lipid friendly. **Explanation:** Third-generation oral contraceptive pills (OCPs) were developed to minimize the androgenic side effects associated with earlier generations. They contain progestogens like **Desogestrel, Gestodene, and Norgestimate**. **1. Why Option A is Correct:** Third-generation progestogens are highly selective and possess **minimal androgenic activity**. Unlike older progestins (like Levonorgestrel), they do not antagonize the beneficial effects of estrogen on the lipid profile. Consequently, they are **"lipid-friendly"** because they tend to increase HDL (good cholesterol) and decrease LDL (bad cholesterol), reducing the overall metabolic impact on the liver. **2. Analysis of Incorrect Options:** * **Option B:** Third-generation OCPs actually **increase the risk of Venous Thromboembolism (VTE)** compared to second-generation pills. This is a classic high-yield fact; the risk of VTE is roughly double that of second-generation formulations. * **Option C:** Because these progestogens have high endometrial potency, they generally provide **better cycle control** and *decrease* the risk of breakthrough bleeding compared to older, low-dose formulations. * **Option D:** Desogestrel and other third-generation progestins *can* be used in various contraceptive formats, though Levonorgestrel remains the gold standard for progestin-only emergency contraception. **3. NEET-PG High-Yield Pearls:** * **1st Generation:** Norethynodrel (Historical). * **2nd Generation:** Levonorgestrel (Most common, lowest VTE risk, but most androgenic—causes acne/hirsutism). * **3rd Generation:** Desogestrel, Gestodene (Lipid-friendly, less acne, but **highest VTE risk**). * **4th Generation:** Drospirenone (Anti-mineralocorticoid and anti-androgenic; excellent for PCOS and PMDD). * **Drug of choice for PCOS with hirsutism:** OCPs containing Cyproterone acetate or Drospirenone.

Question 1

Which drug is used for the management of obesity?

Accepted Answer

Orlistat

Answer

Rivastigmine

Answer

Nitrous oxide

Answer

Phenylephrine

Question 2

Bisphosphonates are used in all of the following conditions EXCEPT:

Accepted Answer

Vitamin D excess

Answer

Paget's disease

Answer

Postmenopausal osteoporosis

Answer

Hypercalcemia of malignancy

Question 3

A 45-year-old female patient with a history of diabetes, currently on oral hypoglycemic medication, presents for a routine general checkup. Physical examination reveals truncal obesity. The medication used in her treatment acts by inhibiting which of the following enzymes?

Accepted Answer

CPT-I

Answer

3-KetoacylCoA thiolase

Answer

HMG-CoA lyase

Answer

3-hydroxyacyl-CoA dehydrogenase

Question 4

Which of the following medications are used in the treatment of postmenopausal osteoporosis?

Accepted Answer

Alendronate

Answer

Tamoxifen

Answer

Progesterone

Answer

Estrogen

Question 5

All of the following statements are true except:

Accepted Answer

Oxytocin is used for inducing abortion in the first trimester

Answer

Oxytocin sensitivity is increased during delivery

Answer

Prostaglandins may be given for inducing abortion during the third trimester

Answer

In lactating women, genital stimulation enhances oxytocin release

Question 6

Which of the following is NOT a side effect of steroids given in anti-inflammatory dosages?

Accepted Answer

Hyperkalemia

Answer

Diabetes mellitus

Answer

Osteoporosis

Answer

Na+ and water retention

Question 7

All of the following are indications for the use of Mifepristone, EXCEPT:

Accepted Answer

Postpartum hemorrhage (PPH)

Answer

Abortion

Answer

Cushing syndrome

Answer

Cervical ripening

Question 8

Anabolic steroids may produce the following side effects except?

Accepted Answer

Delayed closure of epiphysis in children

Answer

Precocious puberty in children

Answer

Cholestatic jaundice

Answer

Acne in males and females

Question 9

Which vitamin deficiency is most commonly seen in a pregnant mother who is on phenytoin therapy for epilepsy?

Accepted Answer

Folic acid

Answer

Vitamin B6

Answer

Vitamin B12

Answer

Vitamin A

Question 10

Third generation oral contraceptive pills containing norgestrel and gestodene along with estrogens:

Accepted Answer

Are more lipid friendly

Answer

Decrease the risk of venous thromboembolism

Answer

Increase the risk of breakthrough bleeding

Answer

Are not used for emergency contraception

Endocrine Pharmacology — MCQs

Endocrine Pharmacology — MCQs

On this page

Practice by Chapter

Want unlimited practice?